These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4790664)

  • 1. [Plasmatic levels and urinary elimination of K-strophanthoside after intravenous administration in normal humans].
    Marzo A; Ghirardi P; Riva D; Zaini G; Matteoli E; Marchetti G
    Boll Soc Ital Biol Sper; 1973 Jul; 49(11):633-6. PubMed ID: 4790664
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma levels and urinary elimination of k-strophanthoside in intravenous administration in patients with renal insufficiency].
    Marzo A; Ghirardi P; Maggi GC; Piscitello F; Gobetti F; Marchetti G
    Boll Soc Ital Biol Sper; 1974 Oct; 50(19):1594-7. PubMed ID: 4458745
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasma levels and urinary elimination of k-strophanthoside in venous and muscular administration in cardiac disease patients].
    Marzo A; Ghirardi P; Scalvini A; Delmonte A; Ferrari Bravo A; Goldstein Balocan M; Marchetti G
    Boll Soc Ital Biol Sper; 1974 Oct; 50(19):1589-93. PubMed ID: 4458744
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dialysis and per cent elimination of different cardiac glycosides during haemo- and peritonealdialysis].
    Kramer P; Quellhorst E; Horenkamp J; Scheler F
    Klin Wochenschr; 1972 Jun; 50(12):609-13. PubMed ID: 5052656
    [No Abstract]   [Full Text] [Related]  

  • 5. [Renal elimination kinetics of various several cardiac glycosides].
    Kramer P; Scheler F
    Dtsch Med Wochenschr; 1972 Oct; 97(40):1485-90. PubMed ID: 5071762
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolism of cardioactive glycosides].
    Vergassola R
    Clin Ter; 1971 Apr; 57(2):171-84. PubMed ID: 5165081
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum half-life and renal clearance of 3H peruvoside. Study on normal persons and patients with terminal kidney insufficiency].
    Kramer P; Willms B; Horenkamp J; Scheler F
    Verh Dtsch Ges Kreislaufforsch; 1969; 35():440-4. PubMed ID: 5380625
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiac glycosides].
    Sova J
    Vnitr Lek; 1975 Jun; 21(6):605-15. PubMed ID: 1136209
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the blood level and secretion of radioactively labeled cardiac glycosides following intraduodenal application in the cat].
    Lahrtz H; Sattler RW; van Zwieten PA
    Z Gesamte Exp Med Einschl Exp Chir; 1968; 148(3):210-22. PubMed ID: 5728874
    [No Abstract]   [Full Text] [Related]  

  • 10. [The problem of a formal digitalis dosage].
    Schaefer J; van Zwieten PA
    Dtsch Med Wochenschr; 1973 Jul; 98(28):1377-8. PubMed ID: 4716794
    [No Abstract]   [Full Text] [Related]  

  • 11. Uraemic and normal plasma protein binding of various cardiac glycosides under "in vivo" conditions.
    Kramer P; Köthe E; Scheler F
    Eur J Clin Invest; 1974 Feb; 4(1):53-8. PubMed ID: 4819835
    [No Abstract]   [Full Text] [Related]  

  • 12. Absorption, metabolism and elimination of strophanthus glycosides in man.
    Strobach H; Wirth KE; Rojsathaporn K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):496-500. PubMed ID: 3821940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic use of digitalis and substances with analogous action. Lecture IV].
    Messini M
    Clin Ter; 1971 Feb; 56(4):307-40. PubMed ID: 5581067
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood as a medium for incubating isolated organs: pharmacokinetic studies with 3H-labelled cardiac glycosides].
    Peters T
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):242-3. PubMed ID: 5804266
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasma concentration and biliary and urinary excretion of K-strophanthoside in subjects with biliary fistula (author's transl)].
    Marzo A; Ghirardi P; Di Roberto F; Arisi GP; Maggi GC; Marchetti G
    G Ital Cardiol; 1974; 4(1):56-63. PubMed ID: 4824628
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma levels and urinary excretion of K-strophanthoside (3H) administered rectally to human subjects.
    Ghirardi P; Marzo A; Gianfranceschi M; Bertoli L; Conti F; Mantero O
    Arzneimittelforschung; 1973 Nov; 23(11):1547-50. PubMed ID: 4801661
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the elimination of digitoxin and ouabain in the dog, using the tolerance test of repeated intravenous infusions.
    Greeff K; Greven G; Osswald W; Viana AP
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):326-35. PubMed ID: 5367306
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the determination of cardiotoxicity of cardiac glycosides in cats. 1. General bases and biophysical model for intravenous and intraduodenal infusion experiments].
    Lenke D; Schneider B
    Arzneimittelforschung; 1969 May; 19(5):687-93. PubMed ID: 5819774
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the quantitative effectiveness of k-strophanthin-alpha (Cymarin) in intravenous and oral administration].
    Storz H
    Dtsch Med Wochenschr; 1969 May; 94(22):1166-9. PubMed ID: 5768542
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rational glycoside treatment].
    Kurth U
    Med Welt; 1969 Jun; 23():1336-8. PubMed ID: 5816573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.